 |
| CLA (Conjugated Linoleic Acid) |
Last updated: Nov 19, 2009 |
 |
|
 |
| |
CLA (Conjugated Linoleic Acid) |
|
 |
|
 |
 |
|
 |
| |
CLA (Conjugated Linoleic Acid) is a natural fatty acid found in beef, lamb, turkey and cheese. It is a potent antioxidant, immune stimulant, and anticancer agent in all species of animals tested. It has also been found to 'repartition' their bodies, decreasing fat and increasing lean body mass. One human study confirms these results, with other studies underway.
Dose: 1 to 3gm per day is a normal dose for healthy people. A 70kg individual (154 pounds) would need to consume 3.5gm of CLA daily to receive benefit. Most Americans consume only 1gm of conjugated linoleic acid. Whole milk usually contains 2mg per gram of fat but can be increased by feeding cows corn oil. Supplemental CLA is usually derived from safflower and/or sunflower oil.
Preliminary studies in rat models showed that it has a powerful anticarcinogenic effect against mammary tumors. CLA may have a direct effect by reducing the cancer risk of the target organ. It is noted that, unlike CLA, most anticarcinogenic substances come from plant sources.
Cow's Milk - CLA appears to have an antiproliferative effect on human malignancy. In vitro studies have shown that the milk phospholipid, sphingomyelin, affects three different major antiproliferative pathways which influence oncogenesis. These pathways are inhibition of cell growth, induction of differentiation, and apoptosis.
One-third of all milk triglycerides contain one molecule of butyric acid, which is a potent inhibitor of proliferation and inducer of differentiation and apoptosis in a wide range of neoplastic lines. An animal study suggests that dietary butyrate may also inhibit mammary tumorigenesis, as well as being an important colon cancer protective agent.
Previously, the richest known source of CLA was lamb, with a fairly high CLA content found in beef and dairy products. It has been discovered that the meat of the Western Grey kangarooPreviously, in some circumstances, contains five times as much CLA as lamb's meat. Kangaroo has other benefits as well: it's very lean, and contains lots of iron, zinc and protein.
|
|
 |
|
 |
CLA (Conjugated Linoleic Acid) can help with the following: | |  | | | | Diet | Not recommended for:
A Raw Food/Fruitarian Diet
A Vegetarian Diet
A Vegan Diet | Metabolic |
Problem Caused By Being Overweight | In animals, CLA helped repartition their body weight, decreasing fat and increasing lean body mass. One human study confirms this, while another denies it. The debate continues.
A study shows that obese or overweight people who took CLA supplements every day for six months lost 3 pounds more than those who took a daily pill containing only olive oil, which doesn’t include CLA (placebo). “All effects were independent of diet and exercise,” Einerhand told reporters, adding that waist size and waist-to-hip ratio also dropped in the CLA group (waist size dropped by about 1.2 inches). As for BMI, “individuals with the highest BMI responded best to CLA,” the researchers write. [Digestive Disease Week 2006, May 20-25, 2006]
Another recent study came to a different conclusion. In March 2006, researchers reported in the American Journal of Clinical Nutrition that obese people who took CLA supplements for a year didn’t lose more weight than those who took a placebo.
However, another study supports its use!
Long-term supplementation with conjugated linoleic acid (CLA) reduces body fat mass (BFM) and increases or maintains lean body mass (LBM). However, the regional effect of CLA was not studied. The study aimed to evaluate the effect of CLA per region and safety in healthy, overweight and obese adults.
A total of 118 subjects (BMI: 28-32 kg/m2) were included in a double blind, placebo-controlled trial. Subjects were randomised into two groups supplemented with either 3 x 4 g/d CLA or placebo for 6 months. CLA significantly decreased BFM at month 3 (Delta=- 0 x 9 %, P=0 x 016) and at month 6 (Delta=- 3 x 4 %, P=0 x 043) compared with placebo. The reduction in fat mass was located mostly in the legs (Delta=- 0 x 8 kg, P<0 x 001), and in women (Delta=-1 x 3 kg, P=0 x 046) with BMI >30 kg/m2 (Delta=-1 x 9 kg, P=0 x 011), compared with placebo. The waist-hip ratio decreased significantly (P=0 x 043) compared with placebo. LBM increased (Delta=+0 x 5 kg, P=0 x 049) within the CLA group. Bone mineral content was not affected (P=0 x 70). All changes were independent of diet and physical exercise. Safety parameters including blood lipids, inflammatory and diabetogenic markers remained within the normal range. Adverse events did not differ between the groups.
It is concluded that supplementation with CLA in healthy, overweight and obese adults decreases BFM in specific regions and is well tolerated. [Lipid Nutrition, press release; Mar 2007] |
| Risks |
Increased Risk of Breast Cancer | For breast cancer prevention and treatment, it is suggested that 6 to 10 750mg capsules of CLA be taken daily. When taking CLA, the breast cancer patient also must take soy. |
| Tumors, Malignant |
Breast Cancer | For breast cancer prevention and treatment, it is suggested that 6 to 10 750mg capsules of CLA be taken daily. When taking CLA, the breast cancer patient also must take soy. |
|
| |  | |  |
KEY |  | May do some good |  |  | Likely to help |  |  | Avoid absolutely |
|
 |